Connor & Connor PLLC

JULY 19, 2018

Durrett graduated from Boyd School of Law in 2008 and practiced law in Nevada and California before choosing to dedicate her efforts to the NDA full-time. The Association also supported legislation that implemented consumer safety rules, such as limits on servings and requiring child-resistant packaging.

Dispensary 56

Dispensary Programs Legislation Recreational 56

Cannabis Law Report

NOVEMBER 24, 2021

However, the nature of the government regulations and the subsequent complexity of prescribing, as well as doctors’ safety uncertainties and the stigma of the plant, remain contributing barriers to patient access. 2018 ; Frankhauser 2008 ). The review, however, did not cover patient access to medicinal cannabis.

Research and Development 52

Research and Development Medicine Access Media 52

MMJ Recs

FEBRUARY 23, 2024

The foundational framework was laid with the establishment of the Michigan Medical Marijuana Program in 2008, signalling the state’s commitment to providing legal access to cannabis for qualified patients. Patients benefit from a broad spectrum of cannabis products addressing various medical conditions.

Marijuana 52

Marijuana Supply Chain Research and Development Dispensary 52

Cannabis Law Report

JUNE 25, 2021

Nutt will lead Awakn’s neuroscience research of psychedelic compounds for treating a broad range of addictions where the consequences for the patient, their family, and society are at present most severe. Nutt’s existing role as Chair of Awakn’s Scientific Advisory Board, Prof.

Research and Development 51

Research and Development Therapy Medicine Pets 51

Cannabis Law Report

APRIL 8, 2022

The FDA formally decided to open the door to psychedelic research in human participants, and later accepted MAPS’ Phase 1 MDMA safety and tolerance study protocol. MAPS completed the first Phase 1 safety study with MDMA and resumed working on a protocol for anxiety associated with cancer. Rick Doblin, Ph.D., Source: [link].

Clinical Trials 52

Clinical Trials Therapy Research and Development DEA 52

Cannabis Law Report

MARCH 20, 2019

There are a couple of Panels that are certainly timely in view of the description of California’s regulation of its cannabis industry by those who claim to be most knowledgeable regarding the cannabis industry as maladroit: State of Cannabis Regulations , moderated by Sean Luse, Berkeley Patients Group; and.

Policy 51

Policy Collective Business Legislation 51

Healer

MAY 25, 2021

Here’s what I’d like you to know: Patients report adding THCA and CBDA significantly changed their chronic, inflammation-based conditions including pain and insomnia. Patients report feeling the effects quickly and the benefits continue to build over 30 days . 2008): 271-280. [5] CBDA vs. CBD. 4] Zuardi, Antonio Waldo.

Cannabinoids 52

Cannabinoids THC Research and Development CBD 52

Healer

MAY 25, 2021

Here’s what I’d like you to know: Patients report adding THCA and CBDA significantly changed their chronic, inflammation-based conditions including pain and insomnia. Patients report feeling the effects quickly and the benefits continue to build over 30 days . 2008): 271-280. [5] CBDA vs. CBD. 4] Zuardi, Antonio Waldo.

Cannabinoids 52

Cannabinoids THC Research and Development CBD 52

Cannabis Law Report

JULY 31, 2019

3] The CSA established five schedules of controlled substances, with Schedule I substances defined as those which have a high potential for abuse, no currently accepted medical use in the United States, and a lack of accepted safety for use under medical supervision. [4] Health and Safety Code § 11362.5. [7] 801, et seq. [4]

Law 40

Law Legalization Marijuana Policy 40

Cannabis Law Report

OCTOBER 29, 2019

ElleVet Sciences is pleased to announce the results and publication of the first safety study on the use of hemp CBD/CBDA. The 12-week safety study, conducted by Dr. Joseph Wakshlag, DVM, Ph.D., Dr. Wakshlag is currently available for interviews to discuss the results of the safety study as well as his clinical trials.

Safety 45

Safety CBD Clinical Trials Oil 45

Veriheal

OCTOBER 1, 2020

In 2004, cannabis was reclassified as a class C drug but was reinstated to Class B in 2008 following Prime Minister Gordon Brown’s decision to go against the advice offered up by the Advisory Council on the Misuse of Drugs. . As you can see, cannabis is classified as a class B drug alongside the likes of ketamine and amphetamines.

Legalization 105

Legalization Oil Medicine Media 105

Veriheal

OCTOBER 27, 2020

Robert started his career with the NYPD back in 2008. While working as part of the school safety task force in 2010, Robert received a sprained shoulder and two fractured shin bones from wrestling a student that had assaulted a member of the staff. Under state law, medical cannabis patients are categorized as disabled.

Chronic Pain 121

Chronic Pain Cannabis Conditions Medicine 121

The Cannigma

JANUARY 13, 2023

The fact that migraine is now ranked as the second leading cause of years lived with disability illustrates the magnitude of the negative impact of the disease to patients and their ability to function normally. 1 A 2008 study found serotonin and endocannabinoid levels, including anandamide, were lower in people with chronic migraines.

Terpenes 139

Terpenes Strains THC Treatment 139

Medicinal Genomics

JULY 18, 2023

Aspergillus contamination is responsible for the only documented cannabis-related deaths, and Aspergillus testing is essential to ensuring consumer safety. Due to the increased risk of contracting aspergillosis via organ transplant, some transplant programs have removed patients who use cannabis from their donor waiting list.

Medicine 81

Medicine Patients Cannabis Therapy 81

The Cannigma

DECEMBER 8, 2021

To hear more of JM’s thoughts on the importance of small victories, how to build momentum, and patient rights, tune in today! We’re often that lone voice over on the corner, looking out for consumers, looking out for their rights and for their safety. JMP: It started in 2008. Music by Desca. JMP: Thank you.

Access 97

Access Policy Patients Cannabis 97

SpeedWeed

JULY 19, 2021

“Virginia is committed to legalizing cannabis the right way—by learning from other states, by listening to public health and safety experts and by centering social equity,” Northam said. ” Information about each of the boards and the Governor’s appointments can be found below.

Legalization 52

Legalization Research and Development Safety Legislation 52

Above The Law - Cannabis

AUGUST 21, 2017

215 “collectives” want to start for-profit companies to pursue licensure under the Medicinal and Adult Use Cannabis Regulation and Safety Act (“ MAUCRSA “) and/or merge their collective into a for-profit entity for the same reason. All of this is coming to light now because many Prop. Member voting absolutely matters.

Business 52

Business Legalization Collective Medicine 52

Above The Law - Cannabis

JANUARY 22, 2018

With the beginning of California cannabis licensing under the Medicinal and Adult-Use Cannabis Regulation and Safety Act (MAUCRSA), there has been a lot of confusion and hearsay regarding how the new system will operate. During the transition period, A retailers can sell to qualified patients and M retailers can sell to adults 21 and over.

Marijuana 52

Marijuana Collective Packaging Events 52

Medicinal Genomics

AUGUST 8, 2023

Aspergillus contamination is responsible for the only documented cannabis-related deaths, and Aspergillus testing is essential to ensuring consumer safety. Due to the increased risk of contracting aspergillosis via organ transplant, some transplant programs have removed patients who use cannabis from their donor waiting list.

Medicine 52

Medicine Patients Cannabis Therapy 52

Medicinal Genomics

JULY 18, 2023

Aspergillus contamination is responsible for the only documented cannabis-related deaths, and Aspergillus testing is essential to ensuring consumer safety. Due to the increased risk of contracting aspergillosis via organ transplant, some transplant programs have removed patients who use cannabis from their donor waiting list.

Medicine 52

Medicine Patients Cannabis Therapy 52

SpeedWeed

JULY 19, 2021

“Virginia is committed to legalizing cannabis the right way—by learning from other states, by listening to public health and safety experts and by centering social equity,” Northam said. ” Information about each of the boards and the Governor’s appointments can be found below.

Research and Development 40

Research and Development Safety Legislation Cannabis 40

Kind Meds (Cannabis Education Blog)

FEBRUARY 21, 2022

Evidence for the efficacy and effectiveness of THC-CBD oromucosal spray in symptom management of patients with spasticity due to multiple … Continue reading. More and more fibromyalgia patients are using cannabis products to manage their fibromyalgia symptoms. [7] Safety and Efficacy of Medical Cannabis in Fibromyalgia.

Sleep 52

Sleep Cannabinoids Edibles Oil 52

The Cannigma

SEPTEMBER 12, 2021

The safety of using these products however, is still unknown. Depending on the state you’re in, THC products may be legally accessible to any adult, and other states restrict access to medical patients only. in 2008, 12% in 2012 and 15% in 2018. Who discovered THC? Studies are inconclusive about smoking cannabis use and cancer.

THC 98

THC Research and Development Cannabinoids CBD 98

Above The Law - Cannabis

MARCH 19, 2018

Under Californias Compassionate Use Act of 1996 ( CUA ), qualified patients and their caregivers have been using closed-loop, non-profit cooperatives and collectives to provide consistent access to cannabis for medical use. Each California city and county has treated these collectives and cooperatives differently.

Collective 52

Collective Marijuana Safety Law 52

Cannabis Law Report

MARCH 25, 2019

Permits the distribution of medicinal marihuana only to hospitals and pharmacies registered to dispense Schedule II controlled substances for the purposes of treating glaucoma or the nausea of cancer patients or research approved under the Federal Food, Drug, and Cosmetic Act.”. [ii] 15, 2008 , 122 Stat. 2003, 2004, 2007, 2008, Nov.

Banking 45

Banking Law Marijuana State Laws 45

Cannabis Law Report

JUNE 4, 2021

Sessa is also the Chief Medical Officer of Awakn Life Sciences, and has been a part of scientific and clinical studies administering LSD, psilocybin, ketamine, MDMA and DMT to patients and volunteers. Brian Muraresku. Jonathan is the CEO and founder of Gilgamesh Pharmaceuticals. in/jonathan-sporn-4ba7802/ [link]. Ingmar Gorman. Bruce Tobin.

Research and Development 51

Research and Development Medicine Treatment Pharmaceutical 51

SpeedWeed

MAY 24, 2021

You’re going to have a hard time trying to argue the public safety benefits of closing down an unregulated industry when states that legalized can’t close down their unregulated industry because they taxed it through the roof,” he said. Patients went underground, and the weekend wellness user came into the stores.”. It’s explosive.”.

Legalization 52

Legalization Business Dispensary Retail 52

Cannabis Law Report

JUNE 10, 2021

You’re going to have a hard time trying to argue the public safety benefits of closing down an unregulated industry when states that legalized can’t close down their unregulated industry because they taxed it through the roof,” he said. Patients went underground, and the weekend wellness user came into the stores.”. It’s explosive.”.

Cannabis 51

Cannabis Business Retail Legalization 51